Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
109 studies found for:    dengue
Show Display Options
RSS Create an RSS feed from your search for:
dengue
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
81 Completed A Study of Balapiravir in Patients With Dengue Virus Infection
Condition: Dengue
Interventions: Drug: balapiravir [RO4588161];   Drug: placebo
82 Active, not recruiting Evaluating the Safety and Immune Response to a Dengue Virus Vaccine in Healthy Adults
Condition: Dengue
Interventions: Biological: rDEN2Δ30-7169 vaccine;   Biological: Placebo
83 Completed Safety and Immune Response to Two Doses of rDEN2/4delta30 Dengue Vaccine
Condition: Dengue Fever
Interventions: Biological: rDEN2/4delta30(ME) vaccine;   Biological: Placebo
84 Completed Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3-3'Ddelta30) in Healthy Adults
Condition: Dengue
Intervention: Biological: rDEN3-3'D4delta30
85 Recruiting Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
Condition: Dengue
Interventions: Biological: TetraVax-DV Vaccine - Admixture TV003;   Biological: TetraVax-DV Vaccine - Admixture TV005;   Biological: Placebo
86 Unknown  The Effect of Chloroquine in the Treatment of Patients With Dengue
Condition: Dengue
Interventions: Drug: Placebo;   Drug: Chloroquine
87 Completed Implementation Research of New Dengue Vector Control Tools
Condition: DENGUE
Intervention: Other: Insecticide treated curtains and insecticide treated covers
88 Completed Celgosivir as a Treatment Against Dengue
Condition: Dengue Fever
Interventions: Drug: celgosivir;   Drug: placebo
89 Completed Study of a Dengue Vaccine (V180) in Healthy Adults (V180-001)
Condition: Dengue
Interventions: Biological: Low-dose V180 with low-dose ISCOMATRIX™ adjuvant;   Biological: Low-dose V180 with medium-dose ISCOMATRIX™ adjuvant;   Biological: Medium-dose V180 (non-adjuvanted);   Biological: Medium-dose V180 with low-dose ISCOMATRIX™ adjuvant;   Biological: Medium-dose V180 with medium-dose ISCOMATRIX™ adjuvant;   Biological: Medium-dose V180 with Alhydrogel™ adjuvant;   Biological: High-dose V180 (non-adjuvanted);   Biological: High-dose V180 with low-dose ISCOMATRIX™ adjuvant;   Biological: High-dose V180 with medium-dose ISCOMATRIX™ adjuvant;   Biological: Low-dose V180 with high-dose ISCOMATRIX™ adjuvant;   Biological: Medium-dose V180 with high-dose ISCOMATRIX™ adjuvant;   Biological: High-dose V180 with high-dose ISCOMATRIX™ adjuvant;   Biological: Placebo
90 Not yet recruiting Efficacy and Safety of Ivermectin Against Dengue Infection
Condition: Dengue Fever
Interventions: Drug: 2 days Ivermectin;   Drug: 3 days Ivermectin;   Drug: Placebo
91 Recruiting Evaluating the Safety of and Immune Response to a Dengue Vaccine (TV003) in Healthy Adults, Adolescents, and Children in Thailand
Condition: Dengue
Interventions: Biological: TV003;   Biological: Placebo for TV003
92 Unknown  Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDR
Conditions: Malaria;   Dengue;   Japanese Encephalitis
Interventions: Drug: 20% deet insect repellent;   Drug: placebo control
93 Active, not recruiting Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart
Condition: Dengue
Interventions: Biological: TV003 Vaccine;   Biological: Placebo Vaccine
94 Not yet recruiting A Prospective, Open Label, Treatment Use Study of Patient Safety Following Transfusion of INTERCEPT Platelet Components
Conditions: Chikungunya Virus;   Dengue Virus
Intervention: Biological: INTERCEPT Platelets
95 Completed Phase 1b Study Investigating Safety & Immunogenicity of DENVax Given Intradermally by Needle or Needle Free PharmaJet Injector
Condition: Normal Healthy Adult
Interventions: Biological: DENVax;   Device: PharmaJet Injector
96 Active, not recruiting Sensitivity Study of Diagnostic for Early Detection of Dengue Infection
Condition: Infectious Diseases
Intervention:
97 Completed Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy Adults
Condition: West Nile Fever Encephalitis
Interventions: Biological: WN/DEN4-3'delta30;   Biological: Placebo
98 Recruiting The Pilot Study of Chikungunya Virus Infections in Southern Taiwan
Condition: Chikungunya Virus
Intervention:
99 Completed Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults
Condition: Tick-Borne Encephalitis
Interventions: Biological: LGT(TP21)/DEN4;   Biological: Placebo
100 Completed Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy Adults
Condition: West Nile Fever
Interventions: Biological: WN/DEN4delta30 vaccine;   Biological: Placebo

First Page    Show previous page of results Previous Page (61-80) Studies Shown (81-100) Next Page (101-109) Show next page of results    Last Page
Indicates status has not been verified in more than two years